Functional genomics of p21-activated protein kinases

Informazioni relative al progetto

ID dell’accordo di sovvenzione: HPMI-CT-2001-00133

Data di avvio 1 Novembre 2001

Data di completamento 31 Ottobre 2005

Finanziato da

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Costo totale € 235 200,00

Contributo UE € 235 200,00

Coordinato da

AVENTIS PHARMA DEUTSCHLAND GMBH
Germany

Campo scientifico

• natural sciences › biological sciences › genetics
• natural sciences › biological sciences › biochemistry › biomolecules › proteins

Programma(i)

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Argomento(i)

Data not available

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

BUR - Bursaries, grants, fellowships

Coordinatore

AVENTIS PHARMA DEUTSCHLAND GMBH

• Contributo UE: Nessun dato
• Indirizzo: Industriepark Hoechst, 6879 ; 65926 FRANKFURT AM-MAIN ; Germania
• Costo totale: Nessun dato